Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
49
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Duvall Diantha | CHIEF FINANCIAL OFFICER | 14 | $0 | $6.4K | 2022-06-02 |
| Flechtner Jessica Baker | VP of Research | 77 | $0 | $314.3K | 2022-06-02 |
| Clark William D | President and CEO | 34 | $64.1K | $24.8K | 2022-06-02 |
| SUMER JACQUELYN L | CHIEF LEGAL & COMPLIANCE OFF | 5 | $0 | $150 | 2022-06-01 |
| Siber George | Director | 28 | $422.3K | $1.4K | 2022-05-27 |
| STAPLETON RAYMOND D JR | EVP PHARM SCI & MFG | 5 | $0 | $225 | 2022-05-25 |
| Chang Carmen | 10% Owner | 7 | $22.50M | $770.8K | 2022-05-25 |
| New Enterprise Associates 16, L.P. | 10% Owner | 2 | $0 | $770.8K | 2022-05-25 |
| Makhzoumi Mohamad | 10% Owner | 7 | $22.50M | $770.8K | 2022-05-25 |
| Behbahani Ali | Director, 10% Owner | 12 | $22.50M | $770.8K | 2022-05-25 |
| Florence Anthony A. Jr. | 10% Owner | 7 | $22.50M | $770.8K | 2022-05-25 |
| Sonsini Peter W. | 10% Owner | 7 | $22.50M | $770.8K | 2022-05-25 |
| Walker Paul Edward | 10% Owner | 4 | $7.50M | $770.8K | 2022-05-25 |
| BASKETT FOREST | 10% Owner | 7 | $22.50M | $770.8K | 2022-05-25 |
| SANDELL SCOTT D | 10% Owner | 7 | $22.50M | $770.8K | 2022-05-25 |
| Aakalu Girish N | CHIEF BUSINESS OFFICER | 13 | $0 | $3.8K | 2022-04-04 |
| Davis Thomas Andrew | CHIEF MEDICAL OFFICER | 13 | $0 | $4.4K | 2022-04-04 |
| Lunger John | Director | 1 | $0 | $0 | 2022-03-03 |
| Herron Jennifer Lyn | Director | 1 | $0 | $0 | 2021-09-09 |
| Bosley Katrine | Director | 7 | $0 | $0 | 2021-07-01 |
| Higgins Michael J | Director | 7 | $0 | $0 | 2021-07-01 |
| Schwab Gisela | Director | 2 | $0 | $0 | 2021-07-01 |
| BATE KENNETH | Director | 8 | $0 | $0 | 2021-07-01 |
| NEA 16 GP, LLC | 10% Owner | 2 | $7.50M | $0 | 2020-07-24 |
| MAKOWER JOSHUA | 10% Owner | 5 | $22.50M | $0 | 2020-07-24 |
| GLAXOSMITHKLINE PLC | Other | 10 | $11.23M | $0 | 2020-07-24 |
| Mayer Howard | Director | 4 | $0 | $0 | 2020-06-18 |
| Cooper Ronald Harold Wilfred | Director | 5 | $0 | $0 | 2020-06-18 |
| Singh Narinderjeet | SENIOR VP, PS&M | 11 | $0 | $0 | 2020-06-01 |
| NEA Partners 16, L.P. | 10% Owner | 3 | $15.00M | $0 | 2019-06-24 |
| MOTT DAVID M | 10% Owner | 3 | $15.00M | $0 | 2019-06-24 |
| BARRIS PETER J | 10% Owner | 3 | $15.00M | $0 | 2019-06-24 |
| Carroll Pamela | SVP IMMUNO-ONCOLOGY | 2 | $0 | $0 | 2019-02-07 |
| Meisner Derek M | SENIOR VP AND GENERAL COUNSEL | 2 | $0 | $0 | 2019-02-07 |
| Alfieri Michael | Principle Financial Officer | 2 | $5.4K | $0 | 2019-02-07 |
| Hoffman Eric S | Chief Business Officer | 8 | $24.4K | $0 | 2018-06-21 |
| Poole Jonathan | Chief Financial Officer | 14 | $38.9K | $310.4K | 2018-02-08 |
| HETHERINGTON SETH V | Chief Medical Officer | 13 | $0 | $0 | 2017-02-28 |
| Bitterman Kevin | Director | 13 | $2.79M | $0 | 2016-06-07 |
| HOFFMAN STEPHEN J | Director | 8 | $8.79M | $0 | 2016-06-07 |
| Giannasca Paul | VP of Development | 28 | $0 | $279.1K | 2016-02-02 |
| Polaris Venture Partners Special Founders' Fund V, L.P. | 10% Owner | 4 | $0 | $1.14M | 2015-06-19 |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | 2 | $0 | $125.6K | 2014-08-14 |
| Polaris Venture Partners V, L.P. | 10% Owner | 3 | $0 | $847.3K | 2014-08-12 |
| Farrell Robert E Jr | VP of Finance & Administration | 2 | $0 | $0 | 2014-02-20 |
| JOHNSON & JOHNSON | 10% Owner | 3 | $0 | $0 | 2014-02-10 |
| George Simeon | Director | 7 | $1.73M | $0 | 2014-02-10 |
| Lux Venture Partners II, L.P. | Other | 10 | $0 | $0 | 2014-02-10 |
| Polaris Venture Partners Founders' Fund V, L.P. | 10% Owner | 11 | $2.79M | $0 | 2014-02-10 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Clark William D | President and CEO | S Sale | 2022-06-02 | 2022-06-03 | 4,023 | $0.06 | $241 | 304,377 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | S Sale | 2022-06-02 | 2022-06-03 | 1,578 | $0.06 | $95 | 89,027 | SEC↗ |
| Duvall Diantha | CHIEF FINANCIAL OFFICER | S Sale | 2022-06-02 | 2022-06-03 | 1,355 | $0.06 | $81 | 75,388 | SEC↗ |
| SUMER JACQUELYN L | CHIEF LEGAL & COMPLIANCE OFF | S Sale | 2022-06-01 | 2022-06-02 | 2,500 | $0.06 | $150 | 43,000 | SEC↗ |
| Clark William D | President and CEO | S Sale | 2022-05-31 | 2022-06-02 | 117,244 | $0.06 | $7.0K | 308,400 | SEC↗ |
| Siber George | Director | S Sale | 2022-05-27 | 2022-06-01 | 20,425 | $0.07 | $1.4K | 252 | SEC↗ |
| Duvall Diantha | CHIEF FINANCIAL OFFICER | S Sale | 2022-05-26 | 2022-05-26 | 24,407 | $0.08 | $2.0K | 76,743 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | S Sale | 2022-05-25 | 2022-05-26 | 16,525 | $0.09 | $1.5K | 90,605 | SEC↗ |
| STAPLETON RAYMOND D JR | CHIEF TECHNOLOGY OFFICER | S Sale | 2022-05-25 | 2022-05-26 | 2,500 | $0.09 | $225 | 43,750 | SEC↗ |
| BASKETT FOREST | 10% Owner | S Sale | 2022-05-25 | 2022-05-26 | 4,445,093 | $0.08 | $355.6K | 0 | SEC↗ |
| Behbahani Ali | Director, 10% Owner | S Sale | 2022-05-25 | 2022-05-26 | 4,445,093 | $0.08 | $355.6K | 0 | SEC↗ |
| Chang Carmen | 10% Owner | S Sale | 2022-05-25 | 2022-05-26 | 4,445,093 | $0.08 | $355.6K | 0 | SEC↗ |
| Florence Anthony A. Jr. | 10% Owner | S Sale | 2022-05-25 | 2022-05-26 | 4,445,093 | $0.08 | $355.6K | 0 | SEC↗ |
| Makhzoumi Mohamad | 10% Owner | S Sale | 2022-05-25 | 2022-05-26 | 4,445,093 | $0.08 | $355.6K | 0 | SEC↗ |
| New Enterprise Associates 16, | 10% Owner | S Sale | 2022-05-25 | 2022-05-26 | 4,445,093 | $0.08 | $355.6K | 0 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | S Sale | 2022-05-25 | 2022-05-26 | 4,445,093 | $0.08 | $355.6K | 0 | SEC↗ |
| Sonsini Peter W. | 10% Owner | S Sale | 2022-05-25 | 2022-05-26 | 4,445,093 | $0.08 | $355.6K | 0 | SEC↗ |
| Walker Paul Edward | 10% Owner | S Sale | 2022-05-25 | 2022-05-26 | 4,445,093 | $0.08 | $355.6K | 0 | SEC↗ |
| BASKETT FOREST | 10% Owner | S Sale | 2022-05-24 | 2022-05-26 | 5,931,843 | $0.07 | $415.2K | 4,445,093 | SEC↗ |
| Behbahani Ali | Director, 10% Owner | S Sale | 2022-05-24 | 2022-05-26 | 5,931,843 | $0.07 | $415.2K | 4,445,093 | SEC↗ |
| Chang Carmen | 10% Owner | S Sale | 2022-05-24 | 2022-05-26 | 5,931,843 | $0.07 | $415.2K | 4,445,093 | SEC↗ |
| Florence Anthony A. Jr. | 10% Owner | S Sale | 2022-05-24 | 2022-05-26 | 5,931,843 | $0.07 | $415.2K | 4,445,093 | SEC↗ |
| Makhzoumi Mohamad | 10% Owner | S Sale | 2022-05-24 | 2022-05-26 | 5,931,843 | $0.07 | $415.2K | 4,445,093 | SEC↗ |
| New Enterprise Associates 16, | 10% Owner | S Sale | 2022-05-24 | 2022-05-26 | 5,931,843 | $0.07 | $415.2K | 4,445,093 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | S Sale | 2022-05-24 | 2022-05-26 | 5,931,843 | $0.07 | $415.2K | 4,445,093 | SEC↗ |
| Sonsini Peter W. | 10% Owner | S Sale | 2022-05-24 | 2022-05-26 | 5,931,843 | $0.07 | $415.2K | 4,445,093 | SEC↗ |
| Walker Paul Edward | 10% Owner | S Sale | 2022-05-24 | 2022-05-26 | 5,931,843 | $0.07 | $415.2K | 4,445,093 | SEC↗ |
| Aakalu Girish N | CHIEF BUSINESS OFFICER | S Sale | 2022-04-04 | 2022-04-05 | 963 | $1.25 | $1.2K | 74,459 | SEC↗ |
| Clark William D | President and CEO | S Sale | 2022-04-04 | 2022-04-05 | 3,924 | $1.25 | $4.9K | 369,487 | SEC↗ |
| Davis Thomas Andrew | CHIEF MEDICAL OFFICER | S Sale | 2022-04-04 | 2022-04-05 | 1,091 | $1.25 | $1.4K | 68,330 | SEC↗ |
| Duvall Diantha | CHIEF FINANCIAL OFFICER | S Sale | 2022-04-04 | 2022-04-05 | 963 | $1.25 | $1.2K | 91,775 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | S Sale | 2022-04-04 | 2022-04-05 | 1,212 | $1.25 | $1.5K | 96,193 | SEC↗ |
| Aakalu Girish N | CHIEF BUSINESS OFFICER | S Sale | 2022-03-16 | 2022-03-17 | 2,397 | $1.10 | $2.6K | 75,422 | SEC↗ |
| Clark William D | President and CEO | S Sale | 2022-03-16 | 2022-03-17 | 11,435 | $1.10 | $12.6K | 373,411 | SEC↗ |
| Davis Thomas Andrew | CHIEF MEDICAL OFFICER | S Sale | 2022-03-16 | 2022-03-17 | 2,717 | $1.10 | $3.0K | 69,421 | SEC↗ |
| Duvall Diantha | CHIEF FINANCIAL OFFICER | S Sale | 2022-03-16 | 2022-03-17 | 2,873 | $1.10 | $3.2K | 92,738 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | S Sale | 2022-03-16 | 2022-03-17 | 3,349 | $1.10 | $3.7K | 97,405 | SEC↗ |
| Aakalu Girish N | CHIEF BUSINESS OFFICER | A Award deriv | 2022-03-15 | 2022-03-17 | 93,750 | — | $0 | 93,750 | SEC↗ |
| Clark William D | President and CEO | A Award deriv | 2022-03-15 | 2022-03-17 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Davis Thomas Andrew | CHIEF MEDICAL OFFICER | A Award deriv | 2022-03-15 | 2022-03-17 | 93,750 | — | $0 | 93,750 | SEC↗ |
| Duvall Diantha | CHIEF FINANCIAL OFFICER | A Award deriv | 2022-03-15 | 2022-03-17 | 112,500 | — | $0 | 112,500 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | A Award deriv | 2022-03-15 | 2022-03-17 | 131,250 | — | $0 | 131,250 | SEC↗ |
| STAPLETON RAYMOND D JR | CHIEF TECHNOLOGY OFFICER | A Award deriv | 2022-03-15 | 2022-03-17 | 131,250 | — | $0 | 131,250 | SEC↗ |
| SUMER JACQUELYN L | CHIEF LEGAL & COMPLIANCE OFF | A Award deriv | 2022-03-15 | 2022-03-17 | 112,500 | — | $0 | 112,500 | SEC↗ |
| Aakalu Girish N | CHIEF BUSINESS OFFICER | A Award | 2022-03-15 | 2022-03-17 | 31,250 | — | $0 | 77,819 | SEC↗ |
| Clark William D | President and CEO | A Award | 2022-03-15 | 2022-03-17 | 150,000 | — | $0 | 384,846 | SEC↗ |
| Davis Thomas Andrew | CHIEF MEDICAL OFFICER | A Award | 2022-03-15 | 2022-03-17 | 31,250 | — | $0 | 72,138 | SEC↗ |
| Duvall Diantha | CHIEF FINANCIAL OFFICER | A Award | 2022-03-15 | 2022-03-17 | 37,500 | — | $0 | 95,611 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | A Award | 2022-03-15 | 2022-03-17 | 43,750 | — | $0 | 100,754 | SEC↗ |
| STAPLETON RAYMOND D JR | CHIEF TECHNOLOGY OFFICER | A Award | 2022-03-15 | 2022-03-17 | 43,750 | — | $0 | 46,250 | SEC↗ |
| SUMER JACQUELYN L | CHIEF LEGAL & COMPLIANCE OFF | A Award | 2022-03-15 | 2022-03-17 | 37,500 | — | $0 | 45,500 | SEC↗ |
| Lunger John | Director | A Award deriv | 2022-03-03 | 2022-03-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Herron Jennifer Lyn | Director | A Award deriv | 2021-09-09 | 2021-09-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Higgins Michael J | Director | A Award deriv | 2021-07-01 | 2021-07-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Bosley Katrine | Director | A Award deriv | 2021-07-01 | 2021-07-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BATE KENNETH | Director | A Award deriv | 2021-07-01 | 2021-07-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Director | A Award deriv | 2021-07-01 | 2021-07-02 | 15,000 | — | $0 | 15,000 | SEC↗ | |
| Schwab Gisela | Director | A Award deriv | 2021-07-01 | 2021-07-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Behbahani Ali | Director, 10% Owner | A Award deriv | 2021-07-01 | 2021-07-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| STAPLETON RAYMOND D JR | EVP PHARM SCI & MFG | A Award deriv | 2021-03-15 | 2021-03-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SUMER JACQUELYN L | CHIEF LEGAL & COMPLIANCE OFF | A Award deriv | 2021-03-15 | 2021-03-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Davis Thomas Andrew | CHIEF MEDICAL OFFICER | A Award deriv | 2021-03-15 | 2021-03-17 | 93,750 | — | $0 | 93,750 | SEC↗ |
| Davis Thomas Andrew | CHIEF MEDICAL OFFICER | A Award deriv | 2021-03-15 | 2021-03-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Aakalu Girish N | CHIEF BUSINESS OFFICER | A Award deriv | 2021-03-15 | 2021-03-17 | 93,750 | — | $0 | 93,750 | SEC↗ |
| Aakalu Girish N | CHIEF BUSINESS OFFICER | A Award deriv | 2021-03-15 | 2021-03-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | A Award deriv | 2021-03-15 | 2021-03-17 | 131,250 | — | $0 | 131,250 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | A Award deriv | 2021-03-15 | 2021-03-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Clark William D | President and CEO | A Award deriv | 2021-03-15 | 2021-03-17 | 600,000 | — | $0 | 600,000 | SEC↗ |
| Clark William D | President and CEO | A Award deriv | 2021-03-15 | 2021-03-17 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Duvall Diantha | CHIEF FINANCIAL OFFICER | A Award deriv | 2021-03-15 | 2021-03-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Duvall Diantha | CHIEF FINANCIAL OFFICER | A Award deriv | 2021-03-15 | 2021-03-17 | 112,500 | — | $0 | 112,500 | SEC↗ |
| Davis Thomas Andrew | CHIEF MEDICAL OFFICER | A Award | 2021-03-15 | 2021-03-17 | 31,250 | — | $0 | 31,250 | SEC↗ |
| Aakalu Girish N | CHIEF BUSINESS OFFICER | A Award | 2021-03-15 | 2021-03-17 | 31,250 | — | $0 | 31,250 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | A Award | 2021-03-15 | 2021-03-17 | 43,750 | — | $0 | 43,750 | SEC↗ |
| Clark William D | President and CEO | A Award | 2021-03-15 | 2021-03-17 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Duvall Diantha | CHIEF FINANCIAL OFFICER | A Award | 2021-03-15 | 2021-03-17 | 37,500 | — | $0 | 37,500 | SEC↗ |
| SUMER JACQUELYN L | CHIEF LEGAL & COMPLIANCE OFF | A Award deriv | 2021-03-01 | 2021-03-02 | 115,000 | $3.07 | $353.1K | 115,000 | SEC↗ |
| Clark William D | President and CEO | M Exercise deriv | 2021-02-17 | 2021-02-18 | 19,998 | — | $0 | 86,690 | SEC↗ |
| Clark William D | President and CEO | M Exercise deriv | 2021-02-17 | 2021-02-18 | 16,500 | — | $0 | 171,000 | SEC↗ |
| Clark William D | President and CEO | M Exercise | 2021-02-17 | 2021-02-18 | 16,500 | $1.66 | $27.4K | 43,752 | SEC↗ |
| Clark William D | President and CEO | M Exercise | 2021-02-17 | 2021-02-18 | 19,998 | $2.72 | $54.4K | 63,750 | SEC↗ |
| STAPLETON RAYMOND D JR | EVP PHARM SCI & MFG | A Award deriv | 2021-02-01 | 2021-02-01 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Clark William D | President and CEO | P Buy | 2020-11-10 | 2020-11-10 | 4,760 | $2.06 | $9.8K | 4,760 | SEC↗ |
| NEA 16 GP, LLC | 10% Owner | P Buy deriv | 2020-07-24 | 2020-07-28 | 3,151,260 | $0.13 | $409.7K | 3,151,260 | SEC↗ |
| BASKETT FOREST | 10% Owner | P Buy deriv | 2020-07-24 | 2020-07-28 | 3,151,260 | $0.13 | $409.7K | 3,151,260 | SEC↗ |
| Behbahani Ali | Director, 10% Owner | P Buy deriv | 2020-07-24 | 2020-07-28 | 3,151,260 | $0.13 | $409.7K | 3,151,260 | SEC↗ |
| Chang Carmen | 10% Owner | P Buy deriv | 2020-07-24 | 2020-07-28 | 3,151,260 | $0.13 | $409.7K | 3,151,260 | SEC↗ |
| Florence Anthony A. Jr. | 10% Owner | P Buy deriv | 2020-07-24 | 2020-07-28 | 3,151,260 | $0.13 | $409.7K | 3,151,260 | SEC↗ |
| Makhzoumi Mohamad | 10% Owner | P Buy deriv | 2020-07-24 | 2020-07-28 | 3,151,260 | $0.13 | $409.7K | 3,151,260 | SEC↗ |
| MAKOWER JOSHUA | 10% Owner | P Buy deriv | 2020-07-24 | 2020-07-28 | 3,151,260 | $0.13 | $409.7K | 3,151,260 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | P Buy deriv | 2020-07-24 | 2020-07-28 | 3,151,260 | $0.13 | $409.7K | 3,151,260 | SEC↗ |
| Sonsini Peter W. | 10% Owner | P Buy deriv | 2020-07-24 | 2020-07-28 | 3,151,260 | $0.13 | $409.7K | 3,151,260 | SEC↗ |
| Walker Paul Edward | 10% Owner | P Buy deriv | 2020-07-24 | 2020-07-28 | 3,151,260 | $0.13 | $409.7K | 3,151,260 | SEC↗ |
| GLAXOSMITHKLINE PLC | 10% Owner | P Buy deriv | 2020-07-24 | 2020-07-30 | 1,260,504 | $0.13 | $163.9K | 1,260,504 | SEC↗ |
| NEA 16 GP, LLC | 10% Owner | P Buy | 2020-07-24 | 2020-07-28 | 3,151,260 | $2.25 | $7.09M | 10,376,936 | SEC↗ |
| BASKETT FOREST | 10% Owner | P Buy | 2020-07-24 | 2020-07-28 | 3,151,260 | $2.25 | $7.09M | 10,376,936 | SEC↗ |
| Behbahani Ali | Director, 10% Owner | P Buy | 2020-07-24 | 2020-07-28 | 3,151,260 | $2.25 | $7.09M | 10,376,936 | SEC↗ |
| Chang Carmen | 10% Owner | P Buy | 2020-07-24 | 2020-07-28 | 3,151,260 | $2.25 | $7.09M | 10,376,936 | SEC↗ |
| Florence Anthony A. Jr. | 10% Owner | P Buy | 2020-07-24 | 2020-07-28 | 3,151,260 | $2.25 | $7.09M | 10,376,936 | SEC↗ |
| Makhzoumi Mohamad | 10% Owner | P Buy | 2020-07-24 | 2020-07-28 | 3,151,260 | $2.25 | $7.09M | 10,376,936 | SEC↗ |
| MAKOWER JOSHUA | 10% Owner | P Buy | 2020-07-24 | 2020-07-28 | 3,151,260 | $2.25 | $7.09M | 10,376,936 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | P Buy | 2020-07-24 | 2020-07-28 | 3,151,260 | $2.25 | $7.09M | 10,376,936 | SEC↗ |
| Sonsini Peter W. | 10% Owner | P Buy | 2020-07-24 | 2020-07-28 | 3,151,260 | $2.25 | $7.09M | 10,376,936 | SEC↗ |
| Walker Paul Edward | 10% Owner | P Buy | 2020-07-24 | 2020-07-28 | 3,151,260 | $2.25 | $7.09M | 10,376,936 | SEC↗ |
| GLAXOSMITHKLINE PLC | 10% Owner | P Buy | 2020-07-24 | 2020-07-30 | 1,260,504 | $2.25 | $2.84M | 4,626,389 | SEC↗ |
| Bosley Katrine | Director | A Award deriv | 2020-06-18 | 2020-06-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Cooper Ronald Harold Wilfred | Director | A Award deriv | 2020-06-18 | 2020-06-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Higgins Michael J | Director | A Award deriv | 2020-06-18 | 2020-06-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BATE KENNETH | Director | A Award deriv | 2020-06-18 | 2020-06-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Mayer Howard | Director | A Award deriv | 2020-06-18 | 2020-06-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Siber George | Director | A Award deriv | 2020-06-18 | 2020-06-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Behbahani Ali | Director, 10% Owner | A Award deriv | 2020-06-18 | 2020-06-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Aakalu Girish N | CHIEF BUSINESS OFFICER | A Award deriv | 2020-06-01 | 2020-06-02 | 24,938 | — | $0 | 24,938 | SEC↗ |
| Clark William D | President and CEO | A Award deriv | 2020-06-01 | 2020-06-02 | 106,688 | — | $0 | 106,688 | SEC↗ |
| Duvall Diantha | CHIEF FINANCIAL OFFICER | A Award deriv | 2020-06-01 | 2020-06-02 | 24,938 | — | $0 | 24,938 | SEC↗ |
| Singh Narinderjeet | SENIOR VP, PS&M | A Award deriv | 2020-06-01 | 2020-06-02 | 31,500 | — | $0 | 31,500 | SEC↗ |
| Davis Thomas Andrew | CHIEF MEDICAL OFFICER | A Award deriv | 2020-06-01 | 2020-06-02 | 24,938 | — | $0 | 24,938 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | A Award deriv | 2020-06-01 | 2020-06-02 | 31,500 | — | $0 | 31,500 | SEC↗ |
| Aakalu Girish N | CHIEF BUSINESS OFFICER | A Award | 2020-06-01 | 2020-06-02 | 6,623 | — | $0 | 6,623 | SEC↗ |
| Clark William D | President and CEO | A Award | 2020-06-01 | 2020-06-02 | 27,344 | — | $0 | 27,344 | SEC↗ |
| Duvall Diantha | CHIEF FINANCIAL OFFICER | A Award | 2020-06-01 | 2020-06-02 | 6,623 | — | $0 | 6,623 | SEC↗ |
| Singh Narinderjeet | SENIOR VP, PS&M | A Award | 2020-06-01 | 2020-06-02 | 8,365 | — | $0 | 8,365 | SEC↗ |
| Davis Thomas Andrew | CHIEF MEDICAL OFFICER | A Award | 2020-06-01 | 2020-06-02 | 6,623 | — | $0 | 6,623 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | A Award | 2020-06-01 | 2020-06-02 | 8,365 | — | $0 | 8,365 | SEC↗ |
| Duvall Diantha | CHIEF FINANCIAL OFFICER | A Award deriv | 2020-04-02 | 2020-04-06 | 46,313 | — | $0 | 46,313 | SEC↗ |
| Aakalu Girish N | CHIEF BUSINESS OFFICER | A Award deriv | 2020-04-02 | 2020-04-06 | 46,313 | — | $0 | 46,313 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | A Award deriv | 2020-04-02 | 2020-04-06 | 58,500 | — | $0 | 58,500 | SEC↗ |
| Davis Thomas Andrew | CHIEF MEDICAL OFFICER | A Award deriv | 2020-04-02 | 2020-04-06 | 46,313 | — | $0 | 46,313 | SEC↗ |
| Singh Narinderjeet | SENIOR VP, PS&M | A Award deriv | 2020-04-02 | 2020-04-06 | 58,500 | — | $0 | 58,500 | SEC↗ |
| Clark William D | President and CEO | A Award deriv | 2020-04-02 | 2020-04-06 | 187,500 | — | $0 | 187,500 | SEC↗ |
| Duvall Diantha | CHIEF FINANCIAL OFFICER | A Award | 2020-04-02 | 2020-04-06 | 12,299 | — | $0 | 12,299 | SEC↗ |
| Aakalu Girish N | CHIEF BUSINESS OFFICER | A Award | 2020-04-02 | 2020-04-06 | 12,299 | — | $0 | 12,299 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | A Award | 2020-04-02 | 2020-04-06 | 15,536 | — | $0 | 15,536 | SEC↗ |
| Davis Thomas Andrew | CHIEF MEDICAL OFFICER | A Award | 2020-04-02 | 2020-04-06 | 12,299 | — | $0 | 12,299 | SEC↗ |
| Singh Narinderjeet | SENIOR VP, PS&M | A Award | 2020-04-02 | 2020-04-06 | 15,536 | — | $0 | 15,536 | SEC↗ |
| Clark William D | President and CEO | A Award | 2020-04-02 | 2020-04-06 | 50,783 | — | $0 | 50,783 | SEC↗ |
| Schwab Gisela | Director | A Award deriv | 2020-02-14 | 2020-02-18 | 9,375 | — | $0 | 9,375 | SEC↗ |
| BATE KENNETH | Director | A Award deriv | 2019-07-18 | 2019-07-19 | 5,625 | — | $0 | 5,625 | SEC↗ |
| Bosley Katrine | Director | A Award deriv | 2019-07-18 | 2019-07-19 | 5,625 | — | $0 | 5,625 | SEC↗ |
| Cooper Ronald Harold Wilfred | Director | A Award deriv | 2019-07-18 | 2019-07-19 | 5,625 | — | $0 | 5,625 | SEC↗ |
| Higgins Michael J | Director | A Award deriv | 2019-07-18 | 2019-07-19 | 5,625 | — | $0 | 5,625 | SEC↗ |
| Siber George | Director | A Award deriv | 2019-07-18 | 2019-07-19 | 5,625 | — | $0 | 5,625 | SEC↗ |
| Mayer Howard | Director | A Award deriv | 2019-07-18 | 2019-07-19 | 5,625 | — | $0 | 5,625 | SEC↗ |
| Behbahani Ali | Director, 10% Owner | A Award deriv | 2019-07-18 | 2019-07-19 | 5,625 | — | $0 | 5,625 | SEC↗ |
| NEA Partners 16, L.P. | 10% Owner | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| BARRIS PETER J | 10% Owner | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| BASKETT FOREST | 10% Owner | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| Behbahani Ali | Director, 10% Owner | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| Chang Carmen | 10% Owner | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| Florence Anthony A. Jr. | 10% Owner | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| Makhzoumi Mohamad | 10% Owner | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| MAKOWER JOSHUA | 10% Owner | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| MOTT DAVID M | 10% Owner | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| Sonsini Peter W. | 10% Owner | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| GLAXOSMITHKLINE PLC | 10% Owner | P Buy | 2019-06-24 | 2019-06-26 | 1,857,142 | $3.50 | $6.50M | 3,365,884 | SEC↗ |
| Singh Narinderjeet | SENIOR VP, PS&M | M Exercise deriv | 2019-05-08 | 2019-05-09 | 7,291 | — | $0 | 328,127 | SEC↗ |
| Singh Narinderjeet | SENIOR VP, PS&M | M Exercise | 2019-05-08 | 2019-05-09 | 7,291 | $0.54 | $3.9K | 61,873 | SEC↗ |
| Singh Narinderjeet | SENIOR VP, PS&M | M Exercise deriv | 2019-04-11 | 2019-04-12 | 7,291 | — | $0 | 335,418 | SEC↗ |
| Singh Narinderjeet | SENIOR VP, PS&M | M Exercise | 2019-04-11 | 2019-04-12 | 7,291 | $0.54 | $3.9K | 54,582 | SEC↗ |
| Singh Narinderjeet | SENIOR VP, PS&M | M Exercise deriv | 2019-03-18 | 2019-03-19 | 7,291 | — | $0 | 342,709 | SEC↗ |
| Singh Narinderjeet | SENIOR VP, PS&M | M Exercise | 2019-03-18 | 2019-03-19 | 7,291 | $0.54 | $3.9K | 47,291 | SEC↗ |
| Clark William D | President and CEO | M Exercise deriv | 2019-03-15 | 2019-03-18 | 15,000 | — | $0 | 735,000 | SEC↗ |
| Clark William D | President and CEO | M Exercise | 2019-03-15 | 2019-03-18 | 15,000 | $0.54 | $8.1K | 119,931 | SEC↗ |
| Duvall Diantha | CHIEF FINANCIAL OFFICER | A Award deriv | 2019-03-05 | 2019-03-07 | 475,000 | — | $0 | 475,000 | SEC↗ |
| NEA Partners 16, L.P. | 10% Owner | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| BARRIS PETER J | 10% Owner | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| BASKETT FOREST | 10% Owner | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| Behbahani Ali | Director, 10% Owner | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| Chang Carmen | 10% Owner | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| Florence Anthony A. Jr. | 10% Owner | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| Makhzoumi Mohamad | 10% Owner | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| MAKOWER JOSHUA | 10% Owner | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| MOTT DAVID M | 10% Owner | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| Sonsini Peter W. | 10% Owner | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| NEA Partners 16, L.P. | 10% Owner | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |
| BARRIS PETER J | 10% Owner | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |
| BASKETT FOREST | 10% Owner | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |
| Behbahani Ali | Director, 10% Owner | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |
| Chang Carmen | 10% Owner | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |
| Florence Anthony A. Jr. | 10% Owner | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |
| Makhzoumi Mohamad | 10% Owner | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |
| MAKOWER JOSHUA | 10% Owner | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |
| MOTT DAVID M | 10% Owner | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |
| Sonsini Peter W. | 10% Owner | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |
| Carroll Pamela | SVP IMMUNO-ONCOLOGY | A Award deriv | 2019-02-07 | 2019-02-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | A Award deriv | 2019-02-07 | 2019-02-11 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Meisner Derek M | SENIOR VP AND GENERAL COUNSE | A Award deriv | 2019-02-07 | 2019-02-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Alfieri Michael | Principle Financial Officer | A Award deriv | 2019-02-07 | 2019-02-11 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Aakalu Girish N | CHIEF BUSINESS OFFICER | A Award deriv | 2019-02-07 | 2019-02-11 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Davis Thomas Andrew | CHIEF MEDICAL OFFICER | A Award deriv | 2019-02-07 | 2019-02-11 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Clark William D | President and CEO | A Award deriv | 2019-02-07 | 2019-02-11 | 750,000 | — | $0 | 750,000 | SEC↗ |
| Singh Narinderjeet | SENIOR VP, PS&M | A Award deriv | 2019-02-07 | 2019-02-11 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Aakalu Girish N | CHIEF BUSINESS OFFICER | A Award deriv | 2018-12-13 | 2018-12-14 | 650,000 | — | $0 | 650,000 | SEC↗ |
| Carroll Pamela | SVP IMMUNO-ONCOLOGY | A Award deriv | 2018-11-06 | 2018-11-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | A Award deriv | 2018-11-06 | 2018-11-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Davis Thomas Andrew | CHIEF MEDICAL OFFICER | A Award deriv | 2018-10-01 | 2018-10-02 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Meisner Derek M | SENIOR VP AND GENERAL COUNSE | A Award deriv | 2018-09-20 | 2018-09-21 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Alfieri Michael | Principle Financial Officer | P Buy | 2018-09-13 | 2018-09-14 | 10,000 | $0.54 | $5.4K | 10,000 | SEC↗ |
| Siber George | Director | P Buy | 2018-09-07 | 2018-09-24 | 13,400 | $0.61 | $8.2K | 165,417 | SEC↗ |
| Siber George | Director | P Buy | 2018-09-06 | 2018-09-24 | 25,000 | $0.61 | $15.3K | 152,017 | SEC↗ |
| Siber George | Director | P Buy | 2018-09-05 | 2018-09-24 | 25,000 | $0.62 | $15.5K | 127,017 | SEC↗ |
| Siber George | Director | P Buy | 2018-09-04 | 2018-09-24 | 25,000 | $0.62 | $15.5K | 102,017 | SEC↗ |
| Siber George | Director | P Buy | 2018-08-31 | 2018-09-24 | 25,000 | $0.61 | $15.3K | 77,017 | SEC↗ |
| Siber George | Director | P Buy | 2018-08-30 | 2018-09-24 | 25,000 | $0.61 | $15.3K | 52,017 | SEC↗ |
| Siber George | Director | P Buy | 2018-08-29 | 2018-09-24 | 25,000 | $0.61 | $15.3K | 27,017 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | A Award deriv | 2018-06-21 | 2018-06-25 | 162,500 | — | $0 | 300,000 | SEC↗ |
| Hoffman Eric S | Chief Business Officer | A Award deriv | 2018-06-21 | 2018-06-25 | 162,500 | — | $0 | 300,000 | SEC↗ |
| Clark William D | President and CEO | A Award deriv | 2018-06-21 | 2018-06-25 | 468,000 | — | $0 | 864,000 | SEC↗ |
| Siber George | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Bosley Katrine | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 45,000 | — | $0 | 45,000 | SEC↗ |
| BATE KENNETH | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Mayer Howard | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Cooper Ronald Harold Wilfred | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Higgins Michael J | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Behbahani Ali | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Behbahani Ali | Director | A Award deriv | 2018-02-08 | 2018-02-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hoffman Eric S | Chief Business Officer | A Award deriv | 2018-02-08 | 2018-02-12 | 137,500 | — | $0 | 137,500 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | A Award deriv | 2018-02-08 | 2018-02-12 | 137,500 | — | $0 | 137,500 | SEC↗ |
| Poole Jonathan | Chief Financial Officer | A Award deriv | 2018-02-08 | 2018-02-12 | 217,708 | — | $0 | 217,708 | SEC↗ |
| Clark William D | President and CEO | A Award deriv | 2018-02-08 | 2018-02-12 | 396,000 | — | $0 | 396,000 | SEC↗ |
| Clark William D | President and CEO | P Buy | 2018-01-17 | 2018-01-19 | 25,000 | $0.80 | $20.0K | 82,931 | SEC↗ |
| Poole Jonathan | Chief Financial Officer | M Exercise deriv | 2017-07-24 | 2017-07-24 | 45,000 | — | $0 | 90,000 | SEC↗ |
| Poole Jonathan | Chief Financial Officer | S Sale | 2017-07-24 | 2017-07-24 | 45,000 | $6.00 | $270.0K | 39,247 | SEC↗ |
| Poole Jonathan | Chief Financial Officer | M Exercise | 2017-07-24 | 2017-07-24 | 45,000 | $3.09 | $139.1K | 84,247 | SEC↗ |
| Siber George | Director | A Award deriv | 2017-06-13 | 2017-06-15 | 15,000 | $5.34 | $80.1K | 15,000 | SEC↗ |
| Bosley Katrine | Director | A Award deriv | 2017-06-13 | 2017-06-15 | 15,000 | $5.34 | $80.1K | 15,000 | SEC↗ |
| Cooper Ronald Harold Wilfred | Director | A Award deriv | 2017-06-13 | 2017-06-15 | 15,000 | $5.34 | $80.1K | 15,000 | SEC↗ |
| BATE KENNETH | Director | A Award deriv | 2017-06-13 | 2017-06-15 | 15,000 | $5.34 | $80.1K | 15,000 | SEC↗ |
| Higgins Michael J | Director | A Award deriv | 2017-06-13 | 2017-06-15 | 15,000 | $5.34 | $80.1K | 15,000 | SEC↗ |
| Siber George | Director | M Exercise deriv | 2017-05-19 | 2017-05-22 | 11,230 | $2.38 | $26.7K | 0 | SEC↗ |
| Siber George | Director | M Exercise deriv | 2017-05-19 | 2017-05-22 | 11,057 | $2.86 | $31.6K | 0 | SEC↗ |
| Siber George | Director | M Exercise | 2017-05-19 | 2017-05-22 | 11,057 | $2.86 | $31.6K | 24,304 | SEC↗ |
| Siber George | Director | M Exercise | 2017-05-19 | 2017-05-22 | 11,230 | $2.38 | $26.7K | 13,247 | SEC↗ |
| Siber George | Director | P Buy | 2017-05-19 | 2017-05-22 | 22,287 | $6.07 | $135.3K | 2,017 | SEC↗ |
| Siber George | Director | M Exercise deriv | 2017-05-18 | 2017-05-22 | 19,281 | $2.38 | $45.9K | 11,230 | SEC↗ |
| Siber George | Director | M Exercise deriv | 2017-05-18 | 2017-05-22 | 1,680 | $2.38 | $4.0K | 0 | SEC↗ |
| Siber George | Director | M Exercise deriv | 2017-05-18 | 2017-05-22 | 10,084 | $1.67 | $16.8K | 0 | SEC↗ |
| Siber George | Director | P Buy | 2017-05-18 | 2017-05-22 | 31,045 | $6.02 | $186.9K | 2,017 | SEC↗ |
| Siber George | Director | M Exercise | 2017-05-18 | 2017-05-22 | 19,281 | $2.38 | $45.9K | 33,062 | SEC↗ |
| Siber George | Director | M Exercise | 2017-05-18 | 2017-05-22 | 10,084 | $1.67 | $16.8K | 13,781 | SEC↗ |
| Siber George | Director | M Exercise | 2017-05-18 | 2017-05-22 | 1,680 | $2.38 | $4.0K | 3,697 | SEC↗ |
| Poole Jonathan | Chief Financial Officer | F Tax w/h | 2017-05-10 | 2017-05-10 | 3,500 | $6.13 | $21.5K | 39,247 | SEC↗ |
| Poole Jonathan | Chief Financial Officer | S Sale | 2017-05-08 | 2017-05-10 | 6,213 | $6.51 | $40.4K | 42,747 | SEC↗ |
| Poole Jonathan | Chief Financial Officer | A Award | 2017-05-03 | 2017-05-10 | 7,937 | — | $0 | 25,150 | SEC↗ |
| Poole Jonathan | Chief Financial Officer | A Award | 2017-05-03 | 2017-05-10 | 23,810 | — | $0 | 48,960 | SEC↗ |
| Mayer Howard | Director | A Award deriv | 2017-03-06 | 2017-03-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| HETHERINGTON SETH V | Chief Medical Officer | A Award deriv | 2017-02-28 | 2017-03-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Hoffman Eric S | Chief Business Officer | A Award deriv | 2017-02-28 | 2017-03-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Poole Jonathan | Chief Financial Officer | A Award deriv | 2017-02-28 | 2017-03-01 | 135,000 | — | $0 | 135,000 | SEC↗ |
| Clark William D | President and CEO | A Award deriv | 2017-02-28 | 2017-03-01 | 288,000 | — | $0 | 288,000 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | A Award deriv | 2017-02-28 | 2017-03-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Flechtner Jessica Baker | Chief Scientific Officer | M Exercise deriv | 2016-12-13 | 2016-12-15 | 6,000 | $3.45 | $20.7K | 50,378 | SEC↗ |
| HETHERINGTON SETH V | Chief Medical Officer | M Exercise deriv | 2016-11-09 | 2016-11-09 | 5,000 | $2.02 | $10.1K | 61,955 | SEC↗ |
| HETHERINGTON SETH V | Chief Medical Officer | M Exercise | 2016-11-09 | 2016-11-09 | 5,000 | $2.02 | $10.1K | 26,000 | SEC↗ |
| Hoffman Eric S | Chief Business Officer | P Buy | 2016-11-08 | 2016-11-09 | 3,000 | $3.59 | $10.8K | 11,790 | SEC↗ |
| Clark William D | President and CEO | P Buy | 2016-11-07 | 2016-11-09 | 2,800 | $3.49 | $9.8K | 52,205 | SEC↗ |
| Hoffman Eric S | Chief Business Officer | P Buy | 2016-11-07 | 2016-11-09 | 4,000 | $3.41 | $13.6K | 8,790 | SEC↗ |
| Poole Jonathan | Chief Financial Officer | P Buy | 2016-11-07 | 2016-11-09 | 7,000 | $3.34 | $23.4K | 17,213 | SEC↗ |
| Bitterman Kevin | Director | A Award deriv | 2016-06-07 | 2016-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HOFFMAN STEPHEN J | Director | A Award deriv | 2016-06-07 | 2016-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Bosley Katrine | Director | A Award deriv | 2016-06-07 | 2016-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Higgins Michael J | Director | A Award deriv | 2016-06-07 | 2016-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BATE KENNETH | Director | A Award deriv | 2016-06-07 | 2016-06-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Siber George | Director | A Award deriv | 2016-06-07 | 2016-06-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Cooper Ronald Harold Wilfred | Director | A Award deriv | 2016-06-07 | 2016-06-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Poole Jonathan | Chief Financial Officer | P Buy | 2016-05-09 | 2016-05-10 | 4,000 | $3.88 | $15.5K | 8,213 | SEC↗ |
| Giannasca Paul | VP of Development | A Award deriv | 2016-02-02 | 2016-02-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Flechtner Jessica Baker | VP of Research | A Award deriv | 2016-02-02 | 2016-02-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Clark William D | President and CEO | A Award deriv | 2016-02-02 | 2016-02-04 | 288,000 | — | $0 | 288,000 | SEC↗ |
| Poole Jonathan | Chief Financial Officer | A Award deriv | 2016-02-02 | 2016-02-04 | 135,000 | — | $0 | 135,000 | SEC↗ |
| HETHERINGTON SETH V | Chief Medical Officer | A Award deriv | 2016-02-02 | 2016-02-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Hoffman Eric S | Chief Business Officer | A Award deriv | 2016-02-02 | 2016-02-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Clark William D | President and CEO | P Buy | 2015-12-16 | 2015-12-16 | 3,800 | $6.45 | $24.5K | 43,607 | SEC↗ |
| Flechtner Jessica Baker | VP of Research | M Exercise deriv | 2015-12-14 | 2015-12-15 | 5,462 | — | $0 | 0 | SEC↗ |
| Flechtner Jessica Baker | VP of Research | M Exercise deriv | 2015-12-14 | 2015-12-15 | 3,444 | — | $0 | 0 | SEC↗ |
| Flechtner Jessica Baker | VP of Research | M Exercise | 2015-12-14 | 2015-12-15 | 3,444 | $2.02 | $7.0K | 10,787 | SEC↗ |
| Flechtner Jessica Baker | VP of Research | M Exercise | 2015-12-14 | 2015-12-15 | 5,462 | $2.02 | $11.0K | 7,343 | SEC↗ |
| HETHERINGTON SETH V | Chief Medical Officer | M Exercise deriv | 2015-12-11 | 2015-12-15 | 5,000 | — | $0 | 66,955 | SEC↗ |
| HETHERINGTON SETH V | Chief Medical Officer | M Exercise | 2015-12-11 | 2015-12-15 | 5,000 | $2.02 | $10.1K | 21,000 | SEC↗ |
| Flechtner Jessica Baker | Sr. VP of Research | M Exercise deriv | 2015-09-01 | 2015-09-03 | 2,229 | — | $0 | 3,444 | SEC↗ |
| Flechtner Jessica Baker | Sr. VP of Research | S Sale | 2015-09-01 | 2015-09-03 | 2,229 | $11.35 | $25.3K | 1,881 | SEC↗ |
| Flechtner Jessica Baker | Sr. VP of Research | M Exercise | 2015-09-01 | 2015-09-03 | 2,229 | $2.02 | $4.5K | 4,110 | SEC↗ |
| HETHERINGTON SETH V | Chief Medical Officer | M Exercise deriv | 2015-08-07 | 2015-08-11 | 2,989 | — | $0 | 11,562 | SEC↗ |
| HETHERINGTON SETH V | Chief Medical Officer | M Exercise deriv | 2015-08-07 | 2015-08-11 | 2,011 | — | $0 | 71,955 | SEC↗ |
| HETHERINGTON SETH V | Chief Medical Officer | M Exercise | 2015-08-07 | 2015-08-11 | 2,989 | $2.02 | $6.0K | 13,989 | SEC↗ |
| HETHERINGTON SETH V | Chief Medical Officer | M Exercise | 2015-08-07 | 2015-08-11 | 2,011 | $2.02 | $4.1K | 16,000 | SEC↗ |
| Flechtner Jessica Baker | Sr. VP of Research | M Exercise deriv | 2015-08-03 | 2015-08-05 | 2,229 | — | $0 | 5,673 | SEC↗ |
| Flechtner Jessica Baker | Sr. VP of Research | M Exercise | 2015-08-03 | 2015-08-05 | 2,229 | $2.02 | $4.5K | 4,110 | SEC↗ |
| Flechtner Jessica Baker | Sr. VP of Research | S Sale | 2015-08-03 | 2015-08-05 | 2,229 | $13.05 | $29.1K | 1,881 | SEC↗ |
| Flechtner Jessica Baker | Sr. VP of Research | M Exercise deriv | 2015-07-01 | 2015-07-06 | 2,229 | — | $0 | 7,902 | SEC↗ |
| Flechtner Jessica Baker | Sr. VP of Research | S Sale | 2015-07-01 | 2015-07-06 | 2,229 | $13.92 | $31.0K | 1,881 | SEC↗ |
| Flechtner Jessica Baker | Sr. VP of Research | M Exercise | 2015-07-01 | 2015-07-06 | 2,229 | $2.02 | $4.5K | 4,110 | SEC↗ |
| Polaris Venture Partners Speci | 10% Owner | S Sale | 2015-06-19 | 2015-06-19 | 1,000 | $13.00 | $13.0K | 1,968,606 | SEC↗ |
| Polaris Venture Partners Speci | 10% Owner | S Sale | 2015-06-18 | 2015-06-19 | 29,004 | $13.04 | $378.2K | 1,969,606 | SEC↗ |
| Polaris Venture Partners Speci | 10% Owner | S Sale | 2015-06-17 | 2015-06-17 | 10,618 | $13.01 | $138.1K | 1,998,610 | SEC↗ |
| Polaris Venture Partners Speci | 10% Owner | S Sale | 2015-06-16 | 2015-06-17 | 46,000 | $13.24 | $609.0K | 2,009,228 | SEC↗ |
| Flechtner Jessica Baker | Sr. VP of Research | M Exercise deriv | 2015-06-01 | 2015-06-02 | 2,229 | — | $0 | 10,131 | SEC↗ |